Critical illness is a major determinant of midazolam clearance in children aged 1 month to 17 years
I Ince, SN De Wildt, MYM Peeters… - Therapeutic drug …, 2012 - journals.lww.com
Background: In children, a large variability in pharmacokinetics of midazolam, a cytochrome
P450 3A4/5 (CYP3A4/5) enzyme substrate, has been described, which cannot be explained …
P450 3A4/5 (CYP3A4/5) enzyme substrate, has been described, which cannot be explained …
The oral bioavailability and metabolism of midazolam in stable critically ill children: a pharmacokinetic microtracing study
BD van Groen, EHJ Krekels, MG Mooij… - Clinical …, 2021 - Wiley Online Library
Midazolam is metabolized by the developmentally regulated intestinal and hepatic drug‐
metabolizing enzyme cytochrome P450 (CYP) 3A4/5. It is frequently administered orally to …
metabolizing enzyme cytochrome P450 (CYP) 3A4/5. It is frequently administered orally to …
Population pharmacokinetics and metabolism of midazolam in pediatric intensive care patients
SN De Wildt, M De Hoog, AA Vinks… - Critical care …, 2003 - journals.lww.com
Interventions The pharmacokinetics of midazolam and metabolites were determined during
and after a continuous infusion of midazolam (0.05–0.4 mg/kg/hr) for 3.8 hrs to 25 days …
and after a continuous infusion of midazolam (0.05–0.4 mg/kg/hr) for 3.8 hrs to 25 days …
Inter-individual variation in midazolam clearance in children
MI Altamimi, H Sammons, I Choonara - Archives of disease in …, 2015 - adc.bmj.com
Objectives To determine the extent of inter-individual variation in clearance of midazolam in
children and establish which factors are responsible for this variation. Methods A systematic …
children and establish which factors are responsible for this variation. Methods A systematic …
Predicting CYP3A‐mediated midazolam metabolism in critically ill neonates, infants, children and adults with inflammation and organ failure
JM Brussee, NJ Vet, EHJ Krekels… - British journal of …, 2018 - Wiley Online Library
Aims Inflammation and organ failure have been reported to have an impact on cytochrome
P450 (CYP) 3A‐mediated clearance of midazolam in critically ill children. Our aim was to …
P450 (CYP) 3A‐mediated clearance of midazolam in critically ill children. Our aim was to …
Inflammation and organ failure severely affect midazolam clearance in critically ill children
NJ Vet, JM Brussee, M de Hoog, MG Mooij… - American journal of …, 2016 - atsjournals.org
Rationale: Various in vitro, animal, and limited human adult studies suggest a profound
inhibitory effect of inflammation and disease on cytochrome P-450 3A (CYP3A)-mediated …
inhibitory effect of inflammation and disease on cytochrome P-450 3A (CYP3A)-mediated …
A novel maturation function for clearance of the cytochrome P450 3A substrate midazolam from preterm neonates to adults
I Ince, SN de Wildt, C Wang, MYM Peeters… - Clinical …, 2013 - Springer
Background and objective Major changes in cytochrome P450 (CYP) 3A activity may be
expected in the first few months of life with, later, relatively limited changes. In this analysis …
expected in the first few months of life with, later, relatively limited changes. In this analysis …
Characterization of intestinal and hepatic CYP3A-mediated metabolism of midazolam in children using a physiological population pharmacokinetic modelling …
JM Brussee, H Yu, EHJ Krekels, S Palić, MJE Brill… - Pharmaceutical …, 2018 - Springer
Purpose Changes in drug absorption and first-pass metabolism have been reported
throughout the pediatric age range. Our aim is to characterize both intestinal and hepatic …
throughout the pediatric age range. Our aim is to characterize both intestinal and hepatic …
Inflammation and cardiovascular status impact midazolam pharmacokinetics in critically ill children: An observational, prospective, controlled study
Altered physiology caused by critical illness may change midazolam pharmacokinetics and
thereby result in adverse reactions and outcomes in this vulnerable patient population. This …
thereby result in adverse reactions and outcomes in this vulnerable patient population. This …
Steady-state plasma concentrations of midazolam in critically ill infants and children
J Hughes, AM Gill, H Mulhearn… - Annals of …, 1996 - journals.sagepub.com
OBJECTIVE: To determine the steady-state plasma concentrations of midazolam in critically
ill infants and children. DESIGN: Prospective uncontrolled study conducted over 18 months …
ill infants and children. DESIGN: Prospective uncontrolled study conducted over 18 months …
相关搜索
- major determinant midazolam clearance
- critical illness midazolam clearance
- major determinant critical illness
- organ failure midazolam clearance
- metabolism of midazolam population pharmacokinetics
- metabolism of midazolam oral bioavailability
- critical illness midazolam therapy
- organ failure midazolam metabolism